Table 3.
Average cost effectiveness ratios for TAILORED and TARGETED intervention arms
| Intervention arm | Health outcome | Monthly cost per participant ($) Mean |
Cost per participant at 6M ($) Mean |
Monthly effectiveness per participant Mean (95% CI) |
ACER ($) Mean |
|---|---|---|---|---|---|
| TAILORED | Weight (kg) | 17.61 | 105.66 | 0.98 (0.20, 1.76) | 107.82 |
| Abdominal circ. (cm) | 1.98 (1.09, 2.87) | 53.36 | |||
| HDL (mg/dL) | 0.66 (−0.92, 2.24) | 160.09 | |||
| SBP (mmHg) | 1.86 (0.38, 3.35) | 56.81 | |||
| DBP (mmHg) | −1.07 (−2.54, 0.40) | −98.75 | |||
| HbA1c (%) | 0.08 (−0.01, 0.18) | 1320.75 | |||
| TARGETED | Weight (kg) | 15.24 | 91.44 | 0.51 (−0.27, 1.29) | 179.29 |
| Abdominal circ. (cm) | 1.30 (0.41, 2.19) | 70.34 | |||
| HDL (mg/dL) | 0.62 (−0.67, 1.92) | 147.48 | |||
| SBP (mmHg) | 0.35 (−1.18, 1.89) | 261.26 | |||
| DBP (mmHg) | −1.97 (−3.36, 0.58) | −46.42 | |||
| HbA1c (%) | 0.03 (−0.07, 0.13) | 3048.00 |